161 related articles for article (PubMed ID: 358479)
1. Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).
Jansen HM; The TH; de Gast GC; Esselink MT; van der Wal AM; Orie NG
Thorax; 1978 Aug; 33(4):429-38. PubMed ID: 358479
[No Abstract] [Full Text] [Related]
2. Trial of BCG immunotherapy in the treatment of resectable sequamous cell carcinoma of the bronchus (stages I and II).
Pouillart P; Mathé G; Palangie T; Schwarzenberg L; Huguenin P; Morin P; Gautier H; Baron A
Recent Results Cancer Res; 1977; (62):151-5. PubMed ID: 341247
[No Abstract] [Full Text] [Related]
3. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
Jansen HM; The TH; Orie NG
Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726
[TBL] [Abstract][Full Text] [Related]
4. Attempt at immunotherapy with living BCG in patients with bronchus carcinoma.
Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G
Recent Results Cancer Res; 1978; 68():260-7. PubMed ID: 752864
[No Abstract] [Full Text] [Related]
5. [Non resectable squamous cell carcinoma of the bronchus. Study of the immunological status as prognosis factor and attempt at immunorestoration with B.C.G. (author's transl)].
Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G; Lededente A; Botto G
Nouv Presse Med; 1978 Jan; 7(4):265-9. PubMed ID: 345229
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity in operable bronchial carcinoma: the effect of injecting irradiated autologous tumour cells and BCG.
Stack BH; McSwan N; Stirling JM; Hole DJ; Parratt D; Spilg WG; Gillis CR; McHattie I; Green AG; White RG; Turner MA
Thorax; 1979 Feb; 34(1):68-73. PubMed ID: 442002
[TBL] [Abstract][Full Text] [Related]
7. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
Browder JP; Chretien PB
Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
[No Abstract] [Full Text] [Related]
8. A stratified randomized study of intradermal BCG in patients with carcinoma of the bronchus: prolongation of quality but not length of life in inoperable patients.
Anthony HM; Madsen KE; Mason MK; Templeman GH
Cancer; 1978 Oct; 42(4):1784-92. PubMed ID: 213186
[TBL] [Abstract][Full Text] [Related]
9. Survival of patients with bronchogenic carcinoma modified by BCG immunotherapy.
Warren SE; Crispen RG; Nika B
Am Surg; 1978 Jul; 44(7):428-31. PubMed ID: 686527
[TBL] [Abstract][Full Text] [Related]
10. A preliminary trial of a novel form of active immunotherapy in squamous cell carcinoma of the lung.
Lachmann PJ; Grant RM; Freedman LS; Sikora K; Bleehen NM
Br J Cancer; 1985 Mar; 51(3):415-7. PubMed ID: 3882114
[No Abstract] [Full Text] [Related]
11. Immunotherapy as an adjuvant to surgery in carcinoma of bronchus. Results in three randomised trials.
Roeslin N; Dumont P; Morand G; Wihlm JM; Witz JP
Eur J Cardiothorac Surg; 1989; 3(5):430-5. PubMed ID: 2483977
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of adjuvant BCG immunotherapy in head and neck cancer.
Taylor SG; Sisson GA; Bytell DE; Raynor WJ
Arch Otolaryngol; 1983 Aug; 109(8):544-9. PubMed ID: 6347154
[TBL] [Abstract][Full Text] [Related]
13. Immunologic alterations and active aspecific immunotherapy in lung cancer patients.
Banna P; Murabito R; Saggio A; Cordopatri F; Riggi M; Campo ME; Cinà C; Latteri S
Ital J Surg Sci; 1983; 13(2):133-7. PubMed ID: 6195126
[TBL] [Abstract][Full Text] [Related]
14. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
[TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence after regional BCG immunotherapy of bronchial cancer.
McKneally MF; Maver C; Kellar S; Lininger L
Recent Results Cancer Res; 1978; 68():286-91. PubMed ID: 752866
[No Abstract] [Full Text] [Related]
16. [Immunorestoration in epidermoid cancer of the bronchi. Therapeutic results (proceedings)].
Pouillart P; Palangie T; Jouve M; Huguenin P; Gautier H; Morin P; Baron A
J Radiol Electrol Med Nucl; 1978 Nov; 59(11):654-7. PubMed ID: 748546
[No Abstract] [Full Text] [Related]
17. [Treatment of bronchial cancer with a water-saline extract of BCG].
Khadzhiev S; Kavaklieva-Dimitrova Ia
Vopr Onkol; 1971; 17(8):51-7. PubMed ID: 4943964
[No Abstract] [Full Text] [Related]
18. [Prognostic value of PPD test in patients with bronchial carcinoma treated by BCG vaccine (author's transl)].
Jakasa D
Plucne Bolesti Tuberk; 1977; 29(3-4):265-8. PubMed ID: 609635
[No Abstract] [Full Text] [Related]
19. Preliminary trends of the EORTC study comparing postoperative chemotherapy, immunotherapy, chemoimmunotherapy or abstention in squamous cell bronchial carcinoma.
Israel L; Depierre A; Sylvester R
Recent Results Cancer Res; 1978; 68():244-5. PubMed ID: 752863
[No Abstract] [Full Text] [Related]
20. Effect of BCG cell-wall skeleton immunotherapy on the peripheral blood lymphocytes in patients with lung cancer after radiotherapy.
Nishikawa H; Yasaki S; Yoshimoto T; Sakatani M; Itoh M; Masuno T; Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
Gan; 1978 Dec; 69(6):819-24. PubMed ID: 750274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
